Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1175 of 1294 entries
View as:

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01272206 Org: User:
Start: 01/31/11 End: 03/31/11 Due: 03/31/12

Comparison of NovoFine® Needles (4 mm vs. 6 mm)

Phase: N/A Priority: Normal
NCT ID: NCT00343343 Org: User:
Start: 06/30/06 End: 08/31/06 Due: 08/31/07

Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01206101 Org: User:
Start: 03/21/12 End: 06/03/13 Due: 06/03/14

RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03745157 Org: User:
Start: 11/21/18 End: 10/29/19 Due: 10/29/20

Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT01507389 Org: User:
Start: 03/31/06 End: 06/30/06 Due: 06/30/07

LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.

Phase: N/A Priority: Normal
NCT ID: NCT02964247 Org: User:
Start: 03/03/17 End: 05/08/18 Due: 05/08/19

Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00184574 Org: User:
Start: 04/30/05 End: 03/31/06 Due: 03/31/07

Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00065130 Org: User:
Start: 04/30/00 End: 12/31/03 Due: 12/31/04

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

Phase: N/A Priority: Normal
NCT ID: NCT05013229 Org: User:
Start: 11/30/21 End: 11/14/23 Due: 11/14/24

Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02994407 Org: User:
Start: 01/30/17 End: 10/15/18 Due: 10/15/19

Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01465152 Org: User:
Start: 03/06/02 End: 10/21/04 Due: 10/21/05

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02568306 Org: User:
Start: 10/05/15 End: 02/07/17 Due: 02/07/18

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00982644 Org: User:
Start: 09/30/09 End: 12/31/10 Due: 12/31/11

A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01138488 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

Phase: N/A Priority: Normal
NCT ID: NCT03745924 Org: User:
Start: 04/01/19 End: 12/15/27 Due: 12/15/28

A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03466567 Org: User:
Start: 03/15/18 End: 07/10/18 Due: 07/10/19

Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01538511 Org: User:
Start: 06/05/06 End: 03/13/07 Due: 03/13/08

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02762578 Org: User:
Start: 05/03/16 End: 06/19/17 Due: 06/19/18

An Observational Study of Patients With Moderate Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05779475 Org: User:
Start: 04/05/23 End: 03/11/30 Due: 03/11/31

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Phase: N/A Priority: Normal
NCT ID: NCT02906917 Org: User:
Start: 09/20/16 End: 12/24/17 Due: 12/24/18

A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver

Phase: N/A Priority: Normal
NCT ID: NCT03357380 Org: User:
Start: 11/28/17 End: 03/20/20 Due: 03/20/21

Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01589653 Org: User:
Start: 05/26/12 End: 07/09/15 Due: 07/09/16

A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02212067 Org: User:
Start: 08/11/14 End: 05/11/15 Due: 05/11/16

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)

Phase: N/A Priority: Normal
NCT ID: NCT05890976 Org: User:
Start: 05/30/23 End: 01/16/25 Due: 01/16/26

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

Phase: N/A Priority: Normal
NCT ID: NCT01484262 Org: User:
Start: 11/14/11 End: 10/31/14 Due: 10/31/15